Keyphrases
Advanced HIV Disease
100%
Hospitalized Patients
100%
Antibiotic Susceptibility Pattern
100%
Bihar
100%
Antibiotics
50%
Clinical Data
25%
Retrospective Analysis
25%
Antimicrobial Resistance
25%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Escherichia Coli
25%
Gentamicin
25%
Sputum
25%
Klebsiella Pneumoniae (K. pneumoniae)
25%
Bacterial Pathogens
25%
Fluoroquinolones
25%
Aminoglycosides
25%
Demographic Data
25%
Piperacillin-tazobactam
25%
Resistance Pattern
25%
Nitrofurantoin
25%
Cotrimoxazole
25%
Meropenem
25%
Third-generation Cephalosporins
25%
Amikacin
25%
Acinetobacter Baumannii (A. baumannii)
25%
Inpatient Unit
25%
Klebsiella Oxytoca
25%
Proteus Mirabilis
25%
Bacterial Isolates
25%
Bacterial Susceptibility Testing
25%
Moderately Resistant
25%
Pathogen Susceptibility
25%
Kirby Bauer Disk Diffusion Method
25%
Isolated Bacteria
25%
Médecins Sans Frontières
25%
Multidrug-resistant Infection
25%
Microbiological Data
25%
INIS
diseases
100%
antibiotics
100%
patients
100%
india
100%
hiv
100%
pathogens
100%
testing
40%
klebsiella
40%
laboratories
20%
data
20%
diffusion
20%
pneumonia
20%
blood
20%
males
20%
units
20%
urine
20%
bacteria
20%
WHO
20%
pseudomonas
20%
escherichia coli
20%
proteus
20%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
HIV
100%
Infectious Agent
100%
Antibiotics
50%
Prevalence
25%
Infection
25%
Antiinfective Agent
25%
Pseudomonas aeruginosa
25%
Aminoglycoside
25%
Antimicrobial Resistance
25%
Escherichia coli
25%
Piperacillin Plus Tazobactam
25%
Quinolone Derivative
25%
Nitrofurantoin
25%
Cotrimoxazole
25%
Gentamicin
25%
Klebsiella pneumoniae
25%
Amikacin
25%
Meropenem
25%
Acinetobacter Baumannii
25%
Klebsiella oxytoca
25%
Proteus mirabilis
25%
Antibiotic Resistance
25%
Third Generation Cephalosporin
25%
Biochemistry, Genetics and Molecular Biology
Infectious Agent
100%
Human Immunodeficiency Virus
100%
Antibiotic Sensitivity
100%
Prevalence
25%
Pseudomonas aeruginosa
25%
Escherichia coli
25%
Disk Diffusion
25%
Antibiotic Resistance
25%
Klebsiella pneumoniae
25%
Gentamicin
25%
Amikacin
25%
Tazobactam
25%
Proteus mirabilis
25%
Aminoglycoside
25%
Acinetobacter Baumannii
25%
Klebsiella oxytoca
25%
Immunology and Microbiology
Infectious Agent
100%
Human Immunodeficiency Virus
100%
Antibiotic Sensitivity
100%
Pseudomonas aeruginosa
25%
Prevalence
25%
Antimicrobial Resistance
25%
Escherichia coli
25%
Disk Diffusion
25%
Sputum
25%
Klebsiella pneumoniae
25%
Acinetobacter Baumannii
25%
Proteus mirabilis
25%
Klebsiella oxytoca
25%